Milestone Pharmaceuticals Inc. (MIST)
MIST Stock Price Chart
Explore Milestone Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze MIST price movements and trends.
MIST Company Profile
Discover essential business fundamentals and corporate details for Milestone Pharmaceuticals Inc. (MIST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 May 2019
Employees
33.00
Website
https://www.milestonepharma.comCEO
Joseph G. Oliveto
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
MIST Financial Timeline
Browse a chronological timeline of Milestone Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.17.
Earnings released on 12 Aug 2025
EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%.
Earnings released on 14 May 2025
EPS came in at -$0.31 falling short of the estimated -$0.19 by -63.16%.
Earnings released on 13 Mar 2025
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%.
Earnings released on 12 Nov 2024
EPS came in at -$0.14 surpassing the estimated -$0.16 by +12.50%.
Earnings released on 8 Aug 2024
EPS came in at -$0.14 surpassing the estimated -$0.19 by +26.32%.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%.
Earnings released on 21 Mar 2024
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%, while revenue for the quarter reached -$868.00K .
Earnings released on 13 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.38 by +7.89%.
Earnings released on 10 Aug 2023
EPS came in at -$0.37 surpassing the estimated -$0.39 by +5.13%.
Earnings released on 11 May 2023
EPS came in at -$0.35 surpassing the estimated -$0.38 by +7.89%, while revenue for the quarter reached $1.00M .
Earnings released on 29 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.35 by +11.43%, while revenue for the quarter reached $3.50M , beating expectations by +200.00%.
Earnings released on 10 Nov 2022
EPS came in at -$0.34 surpassing the estimated -$0.41 by +17.07%, while revenue for the quarter reached $1.50M .
Earnings released on 10 Aug 2022
EPS came in at -$0.39 falling short of the estimated -$0.36 by -8.33%.
Earnings released on 12 May 2022
EPS came in at -$0.33 surpassing the estimated -$0.39 by +15.38%.
Earnings released on 24 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.36 by -11.11%, while revenue for the quarter reached $15.00M .
Earnings released on 12 Nov 2021
EPS came in at -$0.34 surpassing the estimated -$0.38 by +10.53%.
Earnings released on 11 Aug 2021
EPS came in at $0.02 surpassing the estimated -$0.26 by +107.69%, while revenue for the quarter reached $15.00M , beating expectations by +400.00%.
Earnings released on 17 May 2021
EPS came in at -$0.30 surpassing the estimated -$0.33 by +9.09%.
Earnings released on 29 Mar 2021
EPS came in at -$0.23 surpassing the estimated -$0.41 by +43.90%, while revenue for the quarter reached $57.44M .
Earnings released on 13 Nov 2020
EPS came in at -$0.40 surpassing the estimated -$0.49 by +18.37%.
MIST Stock Performance
Access detailed MIST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.